P Gastmeier1, F Schwab, M Behnke, C Geffers. 1. Institut für Hygiene und Umweltmedizin, Charité - Universitätsmedizin Berlin, Deutschland. Petra.Gastmeier@charite.de
Abstract
BACKGROUND: The data of the German hospital nosocomial infection surveillance system (KISS) were used to investigate the association between the frequency of blood cultures (BC) and central venous catheter associated bloodstream infection (CVC-BSI) rates in intensive care units (ICU). METHODS: A questionnaire on the frequency of BCs taken was sent to all ICUs participating in KISS and univariable and multivariable analyses were performed on the results. RESULTS: A total of 223 ICUs provided data. The median number of BC pairs taken in 2006 was 60 with a huge variation from 3.2 to 680 per 1,000 patient days. The mean primary BSI rate was 0.90 per 1,000 patient days and 0.25 BSIs per 1,000 patient days were caused by coagulase negative Staphylococci (CNS). The mean CVC-BSI rate was 1.40 per 1,000 CVC days. In the univariable analysis the blood culture frequency had a significant influence on the CVC-associated BSI rate, considering either all pathogens (p=0.001) or only the subgroup of CNS-related cases (p=0.019). There was also a significant influence of the BC frequency on the CVC-BSI rate considering all pathogens (p=0.004) as well as the subgroup of CNS (p=0.018). Therefore the BC frequency was a significant factor affecting the incidence of BSI and CVC-BSI. According to the multivariable analysis an increase of the BC frequency of 100 BCs per 1,000 patient days leads to a 1.27-fold higher incidence density of CVC-BSI with a 95% confidence interval (95% CI) of 1.01-1.26. A further significant risk factor for CVC-BSI was the length of stay in the ICU with an adjusted incidence rate ratio (IRR) of 1.25 (95% CI 1.15-1.35). To have the status of an interdisciplinary ICU was a significant protective factor (IRR 0.64; 95% CI 0.45-0.92). CONCLUSIONS: If an external benchmarking of ICU CVC-BSI rates is intended an adjustment according to the BC frequency is necessary. The BC frequency itself should be established as a quality indicator in intensive care.
BACKGROUND: The data of the German hospital nosocomial infection surveillance system (KISS) were used to investigate the association between the frequency of blood cultures (BC) and central venous catheter associated bloodstream infection (CVC-BSI) rates in intensive care units (ICU). METHODS: A questionnaire on the frequency of BCs taken was sent to all ICUs participating in KISS and univariable and multivariable analyses were performed on the results. RESULTS: A total of 223 ICUs provided data. The median number of BC pairs taken in 2006 was 60 with a huge variation from 3.2 to 680 per 1,000 patient days. The mean primary BSI rate was 0.90 per 1,000 patient days and 0.25 BSIs per 1,000 patient days were caused by coagulase negative Staphylococci (CNS). The mean CVC-BSI rate was 1.40 per 1,000 CVC days. In the univariable analysis the blood culture frequency had a significant influence on the CVC-associated BSI rate, considering either all pathogens (p=0.001) or only the subgroup of CNS-related cases (p=0.019). There was also a significant influence of the BC frequency on the CVC-BSI rate considering all pathogens (p=0.004) as well as the subgroup of CNS (p=0.018). Therefore the BC frequency was a significant factor affecting the incidence of BSI and CVC-BSI. According to the multivariable analysis an increase of the BC frequency of 100 BCs per 1,000 patient days leads to a 1.27-fold higher incidence density of CVC-BSI with a 95% confidence interval (95% CI) of 1.01-1.26. A further significant risk factor for CVC-BSI was the length of stay in the ICU with an adjusted incidence rate ratio (IRR) of 1.25 (95% CI 1.15-1.35). To have the status of an interdisciplinary ICU was a significant protective factor (IRR 0.64; 95% CI 0.45-0.92). CONCLUSIONS: If an external benchmarking of ICU CVC-BSI rates is intended an adjustment according to the BC frequency is necessary. The BC frequency itself should be established as a quality indicator in intensive care.
Authors: Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel Journal: N Engl J Med Date: 2006-12-28 Impact factor: 91.245
Authors: S Hansen; F Schwab; M Behnke; H Carsauw; P Heczko; I Klavs; O Lyytikäinen; M Palomar; I Riesenfeld Orn; A Savey; E Szilagyi; R Valinteliene; J Fabry; P Gastmeier Journal: J Hosp Infect Date: 2008-09-16 Impact factor: 3.926
Authors: K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte Journal: Anaesthesist Date: 2010-04 Impact factor: 1.041
Authors: Peter J Pronovost; Christine A Goeschel; Elizabeth Colantuoni; Sam Watson; Lisa H Lubomski; Sean M Berenholtz; David A Thompson; David J Sinopoli; Sara Cosgrove; J Bryan Sexton; Jill A Marsteller; Robert C Hyzy; Robert Welsh; Patricia Posa; Kathy Schumacher; Dale Needham Journal: BMJ Date: 2010-02-04
Authors: Heike Raupach-Rosin; Arne Duddeck; Maike Gehrlich; Charlotte Helmke; Johannes Huebner; Mathias W Pletz; Rafael Mikolajczyk; André Karch Journal: Infection Date: 2017-02-15 Impact factor: 3.553
Authors: André Karch; Stefanie Castell; Frank Schwab; Christine Geffers; Hannah Bongartz; Frank M Brunkhorst; Petra Gastmeier; Rafael T Mikolajczyk Journal: J Clin Microbiol Date: 2014-12-17 Impact factor: 5.948
Authors: Oliver Kumpf; Jan-Peter Braun; Alexander Brinkmann; Hanswerner Bause; Martin Bellgardt; Frank Bloos; Rolf Dubb; Clemens Greim; Arnold Kaltwasser; Gernot Marx; Reimer Riessen; Claudia Spies; Jörg Weimann; Gabriele Wöbker; Elke Muhl; Christian Waydhas Journal: Ger Med Sci Date: 2017-08-01
Authors: Jan Walter; Ines Noll; Marcel Feig; Bettina Weiss; Hermann Claus; Guido Werner; Tim Eckmanns; Julia Hermes; Muna Abu Sin Journal: BMC Infect Dis Date: 2017-02-23 Impact factor: 3.090
Authors: Florian Salm; Frank Schwab; Michael Behnke; Frank M Brunkhorst; André Scherag; Christine Geffers; Petra Gastmeier Journal: Antimicrob Resist Infect Control Date: 2018-11-21 Impact factor: 4.887
Authors: Soraya Cherifi; Georges Mascart; Anne Dediste; Marie Hallin; Michèle Gerard; Marie-Laurence Lambert; Baudouin Byl Journal: Antimicrob Resist Infect Control Date: 2013-04-03 Impact factor: 4.887
Authors: Roland P H Schmitz; Peter M Keller; Michael Baier; Stefan Hagel; Mathias W Pletz; Frank M Brunkhorst Journal: Crit Care Date: 2013-10-21 Impact factor: 9.097
Authors: André Karch; Roland P Schmitz; Florian Rißner; Stefanie Castell; Sandra Töpel; Matthias Jakob; Frank M Brunkhorst; Rafael T Mikolajczyk Journal: BMJ Open Date: 2015-12-15 Impact factor: 2.692